ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Live Attenuated Rotavirus Vaccine Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-20S17811
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Live Attenuated Rotavirus Vaccine Market Research Report 2024
BUY CHAPTERS

Global Live Attenuated Rotavirus Vaccine Market Research Report 2024

Code: QYRE-Auto-20S17811
Report
July 2024
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck Sharp & Dohme
GSK
Bharat Biotech
Lanzhou Biological Products Research Institute

Live Attenuated Rotavirus Vaccine Market

Rotavirus spreads easily among infants and young children. The virus can cause severe watery diarrhea, vomiting, fever, and abdominal pain. Children who get rotavirus disease can become dehydrated and may need to be hospitalized. Live attenuated rotavirus vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable.
The global Live Attenuated Rotavirus Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Live Attenuated Rotavirus Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Live Attenuated Rotavirus Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Live Attenuated Rotavirus Vaccine include Merck Sharp & Dohme, GSK, Bharat Biotech, Lanzhou Biological Products Research Institute, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Live Attenuated Rotavirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Attenuated Rotavirus Vaccine.
The Live Attenuated Rotavirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Live Attenuated Rotavirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live Attenuated Rotavirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Live Attenuated Rotavirus Vaccine Market Report

Report Metric Details
Report Name Live Attenuated Rotavirus Vaccine Market
Segment by Type
Segment by Application
  • Hospitals and Clinics
  • Vaccination Sites
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck Sharp & Dohme, GSK, Bharat Biotech, Lanzhou Biological Products Research Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Live Attenuated Rotavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Live Attenuated Rotavirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Live Attenuated Rotavirus Vaccine Market report?

Ans: The main players in the Live Attenuated Rotavirus Vaccine Market are Merck Sharp & Dohme, GSK, Bharat Biotech, Lanzhou Biological Products Research Institute

What are the Application segmentation covered in the Live Attenuated Rotavirus Vaccine Market report?

Ans: The Applications covered in the Live Attenuated Rotavirus Vaccine Market report are Hospitals and Clinics, Vaccination Sites

What are the Type segmentation covered in the Live Attenuated Rotavirus Vaccine Market report?

Ans: The Types covered in the Live Attenuated Rotavirus Vaccine Market report are Monovalent Vaccines, Combination Vaccines

Recommended Reports

Live Attenuated Vaccines

Rotavirus Related Reports

Animal And Veterinary Vaccines

1 Live Attenuated Rotavirus Vaccine Market Overview
1.1 Product Definition
1.2 Live Attenuated Rotavirus Vaccine by Type
1.2.1 Global Live Attenuated Rotavirus Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Monovalent Vaccines
1.2.3 Combination Vaccines
1.3 Live Attenuated Rotavirus Vaccine by Application
1.3.1 Global Live Attenuated Rotavirus Vaccine Market Value by Application (2024-2030)
1.3.2 Hospitals and Clinics
1.3.3 Vaccination Sites
1.4 Global Live Attenuated Rotavirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Live Attenuated Rotavirus Vaccine Revenue 2019-2030
1.4.2 Global Live Attenuated Rotavirus Vaccine Sales 2019-2030
1.4.3 Global Live Attenuated Rotavirus Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Live Attenuated Rotavirus Vaccine Market Competition by Manufacturers
2.1 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Live Attenuated Rotavirus Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Live Attenuated Rotavirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Live Attenuated Rotavirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Live Attenuated Rotavirus Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Live Attenuated Rotavirus Vaccine, Date of Enter into This Industry
2.8 Global Live Attenuated Rotavirus Vaccine Market Competitive Situation and Trends
2.8.1 Global Live Attenuated Rotavirus Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Live Attenuated Rotavirus Vaccine Players Market Share by Revenue
2.8.3 Global Live Attenuated Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Live Attenuated Rotavirus Vaccine Market Scenario by Region
3.1 Global Live Attenuated Rotavirus Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Live Attenuated Rotavirus Vaccine Sales by Region: 2019-2030
3.2.1 Global Live Attenuated Rotavirus Vaccine Sales by Region: 2019-2024
3.2.2 Global Live Attenuated Rotavirus Vaccine Sales by Region: 2025-2030
3.3 Global Live Attenuated Rotavirus Vaccine Revenue by Region: 2019-2030
3.3.1 Global Live Attenuated Rotavirus Vaccine Revenue by Region: 2019-2024
3.3.2 Global Live Attenuated Rotavirus Vaccine Revenue by Region: 2025-2030
3.4 North America Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country
3.4.1 North America Live Attenuated Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Live Attenuated Rotavirus Vaccine Sales by Country (2019-2030)
3.4.3 North America Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Live Attenuated Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Live Attenuated Rotavirus Vaccine Sales by Country (2019-2030)
3.5.3 Europe Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Live Attenuated Rotavirus Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Live Attenuated Rotavirus Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Live Attenuated Rotavirus Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Live Attenuated Rotavirus Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Live Attenuated Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Live Attenuated Rotavirus Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Live Attenuated Rotavirus Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Live Attenuated Rotavirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Live Attenuated Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Live Attenuated Rotavirus Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Live Attenuated Rotavirus Vaccine Sales by Type (2019-2030)
4.1.1 Global Live Attenuated Rotavirus Vaccine Sales by Type (2019-2024)
4.1.2 Global Live Attenuated Rotavirus Vaccine Sales by Type (2025-2030)
4.1.3 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Live Attenuated Rotavirus Vaccine Revenue by Type (2019-2030)
4.2.1 Global Live Attenuated Rotavirus Vaccine Revenue by Type (2019-2024)
4.2.2 Global Live Attenuated Rotavirus Vaccine Revenue by Type (2025-2030)
4.2.3 Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Live Attenuated Rotavirus Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Live Attenuated Rotavirus Vaccine Sales by Application (2019-2030)
5.1.1 Global Live Attenuated Rotavirus Vaccine Sales by Application (2019-2024)
5.1.2 Global Live Attenuated Rotavirus Vaccine Sales by Application (2025-2030)
5.1.3 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Live Attenuated Rotavirus Vaccine Revenue by Application (2019-2030)
5.2.1 Global Live Attenuated Rotavirus Vaccine Revenue by Application (2019-2024)
5.2.2 Global Live Attenuated Rotavirus Vaccine Revenue by Application (2025-2030)
5.2.3 Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Live Attenuated Rotavirus Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck Sharp & Dohme
6.1.1 Merck Sharp & Dohme Company Information
6.1.2 Merck Sharp & Dohme Description and Business Overview
6.1.3 Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Product Portfolio
6.1.5 Merck Sharp & Dohme Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Live Attenuated Rotavirus Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bharat Biotech
6.3.1 Bharat Biotech Company Information
6.3.2 Bharat Biotech Description and Business Overview
6.3.3 Bharat Biotech Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bharat Biotech Live Attenuated Rotavirus Vaccine Product Portfolio
6.3.5 Bharat Biotech Recent Developments/Updates
6.4 Lanzhou Biological Products Research Institute
6.4.1 Lanzhou Biological Products Research Institute Company Information
6.4.2 Lanzhou Biological Products Research Institute Description and Business Overview
6.4.3 Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product Portfolio
6.4.5 Lanzhou Biological Products Research Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Live Attenuated Rotavirus Vaccine Industry Chain Analysis
7.2 Live Attenuated Rotavirus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Live Attenuated Rotavirus Vaccine Production Mode & Process
7.4 Live Attenuated Rotavirus Vaccine Sales and Marketing
7.4.1 Live Attenuated Rotavirus Vaccine Sales Channels
7.4.2 Live Attenuated Rotavirus Vaccine Distributors
7.5 Live Attenuated Rotavirus Vaccine Customers
8 Live Attenuated Rotavirus Vaccine Market Dynamics
8.1 Live Attenuated Rotavirus Vaccine Industry Trends
8.2 Live Attenuated Rotavirus Vaccine Market Drivers
8.3 Live Attenuated Rotavirus Vaccine Market Challenges
8.4 Live Attenuated Rotavirus Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck Sharp & Dohme
GSK
Bharat Biotech
Lanzhou Biological Products Research Institute
List of Tables
 Table 1. Global Live Attenuated Rotavirus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Live Attenuated Rotavirus Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Live Attenuated Rotavirus Vaccine Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Live Attenuated Rotavirus Vaccine Sales (K Dose) of Key Manufacturers (2019-2024)
 Table 5. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Live Attenuated Rotavirus Vaccine Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Live Attenuated Rotavirus Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Live Attenuated Rotavirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Live Attenuated Rotavirus Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Live Attenuated Rotavirus Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Live Attenuated Rotavirus Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Live Attenuated Rotavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Rotavirus Vaccine as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Live Attenuated Rotavirus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Live Attenuated Rotavirus Vaccine Sales by Region (2019-2024) & (K Dose)
 Table 18. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2019-2024)
 Table 19. Global Live Attenuated Rotavirus Vaccine Sales by Region (2025-2030) & (K Dose)
 Table 20. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2025-2030)
 Table 21. Global Live Attenuated Rotavirus Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2019-2024)
 Table 23. Global Live Attenuated Rotavirus Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2025-2030)
 Table 25. North America Live Attenuated Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 27. North America Live Attenuated Rotavirus Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 28. North America Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Live Attenuated Rotavirus Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Live Attenuated Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 32. Europe Live Attenuated Rotavirus Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 33. Europe Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Live Attenuated Rotavirus Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Live Attenuated Rotavirus Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Live Attenuated Rotavirus Vaccine Sales by Region (2019-2024) & (K Dose)
 Table 37. Asia Pacific Live Attenuated Rotavirus Vaccine Sales by Region (2025-2030) & (K Dose)
 Table 38. Asia Pacific Live Attenuated Rotavirus Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Live Attenuated Rotavirus Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Live Attenuated Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 42. Latin America Live Attenuated Rotavirus Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 43. Latin America Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Live Attenuated Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 47. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 48. Middle East and Africa Live Attenuated Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Live Attenuated Rotavirus Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Live Attenuated Rotavirus Vaccine Sales (K Dose) by Type (2019-2024)
 Table 51. Global Live Attenuated Rotavirus Vaccine Sales (K Dose) by Type (2025-2030)
 Table 52. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2019-2024)
 Table 53. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2025-2030)
 Table 54. Global Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2019-2024)
 Table 57. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2025-2030)
 Table 58. Global Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Type (2019-2024)
 Table 59. Global Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Type (2025-2030)
 Table 60. Global Live Attenuated Rotavirus Vaccine Sales (K Dose) by Application (2019-2024)
 Table 61. Global Live Attenuated Rotavirus Vaccine Sales (K Dose) by Application (2025-2030)
 Table 62. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2019-2024)
 Table 63. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2025-2030)
 Table 64. Global Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Live Attenuated Rotavirus Vaccine Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2019-2024)
 Table 67. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2025-2030)
 Table 68. Global Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Application (2019-2024)
 Table 69. Global Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Application (2025-2030)
 Table 70. Merck Sharp & Dohme Company Information
 Table 71. Merck Sharp & Dohme Description and Business Overview
 Table 72. Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 73. Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Product
 Table 74. Merck Sharp & Dohme Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 78. GSK Live Attenuated Rotavirus Vaccine Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Bharat Biotech Company Information
 Table 81. Bharat Biotech Description and Business Overview
 Table 82. Bharat Biotech Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 83. Bharat Biotech Live Attenuated Rotavirus Vaccine Product
 Table 84. Bharat Biotech Recent Developments/Updates
 Table 85. Lanzhou Biological Products Research Institute Company Information
 Table 86. Lanzhou Biological Products Research Institute Description and Business Overview
 Table 87. Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 88. Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product
 Table 89. Lanzhou Biological Products Research Institute Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Live Attenuated Rotavirus Vaccine Distributors List
 Table 93. Live Attenuated Rotavirus Vaccine Customers List
 Table 94. Live Attenuated Rotavirus Vaccine Market Trends
 Table 95. Live Attenuated Rotavirus Vaccine Market Drivers
 Table 96. Live Attenuated Rotavirus Vaccine Market Challenges
 Table 97. Live Attenuated Rotavirus Vaccine Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Live Attenuated Rotavirus Vaccine
 Figure 2. Global Live Attenuated Rotavirus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Live Attenuated Rotavirus Vaccine Market Share by Type: 2023 & 2030
 Figure 4. Monovalent Vaccines Product Picture
 Figure 5. Combination Vaccines Product Picture
 Figure 6. Global Live Attenuated Rotavirus Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Live Attenuated Rotavirus Vaccine Market Share by Application: 2023 & 2030
 Figure 8. Hospitals and Clinics
 Figure 9. Vaccination Sites
 Figure 10. Global Live Attenuated Rotavirus Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Live Attenuated Rotavirus Vaccine Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Live Attenuated Rotavirus Vaccine Sales (2019-2030) & (K Dose)
 Figure 13. Global Live Attenuated Rotavirus Vaccine Average Price (US$/Dose) & (2019-2030)
 Figure 14. Live Attenuated Rotavirus Vaccine Report Years Considered
 Figure 15. Live Attenuated Rotavirus Vaccine Sales Share by Manufacturers in 2023
 Figure 16. Global Live Attenuated Rotavirus Vaccine Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Live Attenuated Rotavirus Vaccine Players: Market Share by Revenue in Live Attenuated Rotavirus Vaccine in 2023
 Figure 18. Live Attenuated Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Live Attenuated Rotavirus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2019-2030)
 Figure 21. North America Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2019-2030)
 Figure 22. United States Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2019-2030)
 Figure 25. Europe Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2019-2030)
 Figure 33. China Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Latin America Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2019-2030)
 Figure 41. Mexico Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Brazil Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Argentina Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Colombia Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Middle East and Africa Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2019-2030)
 Figure 46. Middle East and Africa Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2019-2030)
 Figure 47. Turkey Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. UAE Live Attenuated Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Global Sales Market Share of Live Attenuated Rotavirus Vaccine by Type (2019-2030)
 Figure 51. Global Revenue Market Share of Live Attenuated Rotavirus Vaccine by Type (2019-2030)
 Figure 52. Global Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Type (2019-2030)
 Figure 53. Global Sales Market Share of Live Attenuated Rotavirus Vaccine by Application (2019-2030)
 Figure 54. Global Revenue Market Share of Live Attenuated Rotavirus Vaccine by Application (2019-2030)
 Figure 55. Global Live Attenuated Rotavirus Vaccine Price (US$/Dose) by Application (2019-2030)
 Figure 56. Live Attenuated Rotavirus Vaccine Value Chain
 Figure 57. Live Attenuated Rotavirus Vaccine Production Process
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Oral Live Attenuated Rotavirus Vaccine Market Research Report 2024
Global Rotavirus Vaccine Market Research Report 2024
Global Multivalent Oral Rotavirus Vaccine Market Research Report 2024
Global Live Attenuated Vaccine for Pig Market Research Report 2024
Bovine Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rotavirus Vaccines Market Insights Forecast to 2030
Varicella Virus Attenuated Live Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rotavirus Infection Therapeutics Market Research Report 2024
Oral Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Transmissble Gastroenteritis Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Live Attenuated Vaccine Market Research Report 2024
Global Live Attenuated Polio Vaccine Market Research Report 2024
Live Attenuated Japanese Encephalitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Attenuated Vaccines for Pets Market Research Report 2025
Global Varicella Attenuated Live Vaccine Market Research Report 2025
Oral Live Cholera Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Live and Attenuated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Gastroenteritis Drugs Market Research Report 2024
Cholera Vaccines Oral Live Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Vaccines Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions